Health catalyst, inc. (HCAT)
CashFlow / Yearly
Dec'19Dec'18Dec'17
Cash flows from operating activities
Net loss

-60,096

-61,984

-47,035

Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation and amortization

9,212

7,412

5,892

Loss on extinguishment of debt

-1,670

0

0

Amortization of debt discount and issuance costs

1,081

533

153

Investment discount and premium amortization

615

143

-72

Change in fair value of warrant liability

0

-34

47

Gain on sale of property and equipment

39

29

47

Stock-based compensation expense

17,844

4,198

4,241

Deferred tax benefit

40

-163

14

Other

15

0

0

Change in operating assets and liabilities:
Accounts receivable, net

-127

3,627

-4,442

Deferred costs

288

-113

-461

Prepaid expenses and other assets

1,308

1,334

815

Operating lease right-of-use assets

-2,557

3,942

-1,650

Accounts payable, accrued liabilities, and other liabilities

-86

4,588

-6,289

Deferred revenue

77

10,317

2,126

Operating lease liabilities

-2,345

3,799

-1,741

Net cash used in operating activities

-32,184

-40,296

-36,829

Cash flows from investing activities
Purchases of property and equipment

2,399

2,275

2,466

Proceeds from the sale of property and equipment

62

29

47

Purchase of short-term investments

256,007

13,993

46,422

Proceeds from the sale and maturity of short-term investments

50,677

37,870

72,127

Purchase of intangible assets

1,935

228

878

Net cash provided by (used in) investing activities

-209,602

21,403

22,408

Cash flows from financing activities
Proceeds from initial public offering, net of underwriters' discounts and commissions

194,649

0

0

Proceeds from the issuance of redeemable convertible preferred stock, net of issuance costs

12,073

33,987

23,787

Proceeds from exercise of stock options

2,656

3,045

76

Proceeds from employee stock purchase plan

2,978

0

0

Payments for Repurchase of Common Stock

0

8,712

0

Payment of SVB line of credit and mezzanine loan

21,821

0

0

Proceeds from credit facilities, net of debt issuance costs

47,169

9,950

9,787

Payments of acquisition-related consideration

1,713

13,924

8,779

Payments of deferred offering costs

4,610

0

0

Net cash provided by financing activities

231,381

24,346

24,871

Effect of exchange rate changes

6

0

0

Net increase in cash and cash equivalents

-10,399

5,453

10,450

Cash paid for income taxes

19

31

66

Cash paid for interest

5,557

3,937

1,032

Supplemental disclosures of non-cash investing and financing information
Redeemable convertible preferred stock accretion

180,826

52,037

11,745

Deferred offering costs included in accounts payable and accrued liabilities

0

100

0

Series E redeemable convertible preferred stock allocated to business combination

0

2,252

0

Purchase of intangible assets included in accounts payable and accrued liabilities

1,626

0

675

Purchase of property and equipment included in accounts payable and accrued liabilities

209

84

3

Supplemental disclosures of cash flow information related to leases
Supplemental disclosures of cash flow information related to leases
Cash paid for operating lease liabilities in operating cash flows

3,248

3,146

1,891

Operating lease right-of-use assets obtained in exchange for operating lease obligations

581

6,641

0